190 related articles for article (PubMed ID: 36971680)
1. Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma.
Chen Q; Chen S; Wang J; Zhao Y; Ye X; Fu Y; Liu Y
Aging (Albany NY); 2023 Mar; 15(6):2293-2307. PubMed ID: 36971680
[TBL] [Abstract][Full Text] [Related]
2. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
Chen J; Fu Y; Hu J; He J
Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
[TBL] [Abstract][Full Text] [Related]
4. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
5. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
6. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
7. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
8. Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma.
Xiao L; Li Q; Huang Y; Fan Z; Ma L; Liu B; Yuan X
J Healthc Eng; 2022; 2022():7651758. PubMed ID: 35251577
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma.
Wang S; Cai W; Li J; An W; Zheng H; Liao M
Biochem Genet; 2022 Dec; 60(6):1934-1945. PubMed ID: 35169964
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
Li F; Niu Y; Zhao W; Yan C; Qi Y
Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
[TBL] [Abstract][Full Text] [Related]
11. A promising prognostic signature for lung adenocarcinoma (LUAD) patients basing on 6 hypoxia-related genes.
Luo J; Du X
Medicine (Baltimore); 2021 Dec; 100(50):e28237. PubMed ID: 34918689
[TBL] [Abstract][Full Text] [Related]
12. Identification of metabolism-related gene signature in lung adenocarcinoma.
Wang N; Wang H
Medicine (Baltimore); 2023 Nov; 102(47):e36267. PubMed ID: 38013279
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients.
Shao J; Zhang B; Kuai L; Li Q
Bioengineered; 2021 Dec; 12(1):6186-6200. PubMed ID: 34486476
[TBL] [Abstract][Full Text] [Related]
14. Development of a copper metabolism-related gene signature in lung adenocarcinoma.
Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S
Front Immunol; 2022; 13():1040668. PubMed ID: 36524120
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma.
Jin D; Song Y; Chen Y; Zhang P
Biomed Res Int; 2020; 2020():7929132. PubMed ID: 32596372
[TBL] [Abstract][Full Text] [Related]
16. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
He J; Zhang W; Li F; Yu Y
Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
[TBL] [Abstract][Full Text] [Related]
17. Construction of a hypoxic immune microenvironment associated gene-based model for prognosis prediction of lung adenocarcinoma.
Lin GY; Wu S; Gao ZS; Wu LH; Yan JJ; Guo XQ; Wang ZY
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3807-3826. PubMed ID: 35731050
[TBL] [Abstract][Full Text] [Related]
18. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
Zhou X; Zhao M; Fan Y; Xu Y
PeerJ; 2024; 12():e16616. PubMed ID: 38213773
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
Lin L; Zhang W
Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
